ABBVIE SA
RUT: 21.648.086.0016
RUPE: ACTIVO
Montevideo
Monto Total Contratado
$U 3,4 millones
$U 3.391.622 (~US$ 80.753)
Contratos Ganados
262
Adjudicaciones oficiales registradas
Organismos Compradores
5
Clientes en el sector público
Domicilio Fiscal
Italia Avda 7519
Montevideo (Montevideo)
Distribución por Organismo Comprador
| Organismo Comprador | Compras | Monto Total ($U) |
|---|---|---|
| Dirección General de la Salud | 248 | $U 3.348.146 |
| Hospital Pasteur | 11 | $U 30.230 |
| Centro Hospitalario Pereira Rossell | 1 | $U 4.534 |
| Centro Departamental de Flores | 1 | $U 4.534 |
| Hospital Español | 1 | $U 4.177 |
Historial de Contrataciones
| Fecha | Objeto | Monto ($U) | Detalle |
|---|---|---|---|
| 20/01/2025 | SEVOFLORANO (SOLUCION INHALATORIA) | $U 4.534 | Ver → |
| 17/01/2025 | SEVOFLORANO (SOLUCION INHALATORIA) | $U 4.534 | Ver → |
| 27/12/2024 | RISANKIZUMAB | $U 368.629 | Ver → |
| 25/03/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 25/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 25/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 25/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 22/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 19/03/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 19/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 14/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 14/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 14/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 13/03/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 13/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 13/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 12/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 12/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 12/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 11/03/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 11/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 11/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 11/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 08/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 08/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 08/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 08/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 08/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 08/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 08/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 1.950 | Ver → |
| 06/03/2024 | RISANKIZUMAB | $U 175.509 | Ver → |
| 06/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 06/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 05/03/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 05/03/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 01/03/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 01/03/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 29/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 29/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 29/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 29/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 27/02/2024 | ADALIMUMAB (INYECTABLE) | $U 56.204 | Ver → |
| 27/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 23/02/2024 | RISANKIZUMAB | $U 175.509 | Ver → |
| 22/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 21/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 21/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 21/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 20/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 19/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 19/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 19/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 19/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 1.950 | Ver → |
| 15/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 15/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 15/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 14/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 14/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 14/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 14/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 14/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 14/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 14/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 09/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 08/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 08/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 08/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 07/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 07/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 06/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 06/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 06/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 1.950 | Ver → |
| 06/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 1.950 | Ver → |
| 05/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 05/02/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 05/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 02/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 01/02/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 01/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 01/02/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 31/01/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 31/01/2024 | UPADACITINIB (COMPRIMIDO) | $U 1.950 | Ver → |
| 30/01/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 26/01/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 26/01/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 25/01/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 25/01/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 25/01/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 23/01/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 19/01/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 19/01/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |
| 18/01/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 18/01/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 17/01/2024 | RISANKIZUMAB | $U 175.509 | Ver → |
| 17/01/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 17/01/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 16/01/2024 | UPADACITINIB (COMPRIMIDO) | $U 3.900 | Ver → |
| 16/01/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 16/01/2024 | VENETOCLAX | $U 2.769 | Ver → |
| 15/01/2024 | ADALIMUMAB (INYECTABLE) | $U 28.102 | Ver → |